Category: biotech

.After antibody-drug conjugate (ADC) professional Seagen was sold to Pfizer in 2013 for a monstrous $43 billion, former CEO David Epstein claimed he was actually

.Surrounded by the genetic medicines branches ethnicity, Flagship Pioneering is actually unveiling a new business to assist biotechs adjust the preciseness of their treatments.The project

.Ferocious Biotech Associate Editor Gabrielle Masson offered the 2024 lesson of Brutal 15 champions on the flooring of the Stock market on Wednesday.Masson appeared on

.Allow’s dive into a conversation along with Ayla Ellison, Brutal Biotech Managing Editor and also Michelle Benz as they cover the highlights and exhilaration encompassing

.FibroGen is significantly reorganizing its business, laying off 75% of its own U.S. team as well as quiting financial investment in its own lead applicant

.After F2G’s very first effort to get a new lesson of antifungal to market was actually wrecked due to the FDA, the U.K.-based biotech has

.The FDA has actually executed a partial hang on a period 3 non-small tissue lung cancer cells trial run by BioNTech and OncoC4 after finding

.The FDA has placed Kezar Life Sciences’ lupus trial on hold after the biotech flagged 4 fatalities during the course of the phase 2b study.Kezar

.Five months after signing off on Power Therapeutics’ Pivya as the very first brand-new treatment for simple urinary system diseases (uUTIs) in more than twenty

.After pushing back the decision meeting for Applied Therapies’ metabolic disorder drug govorestat, the FDA has right now chosen that an intended consultatory board meeting